Alzheimer’s Drug Discovery Foundation – Prevention RFP
Ends on 15 September 2025
The ADDF seeks to support precision prevention studies, combination therapy studies, and comparative effectiveness research that probe whether the use or choice of interventions may reduce the risk of Alzheimer’s disease or other dementias. Studies that are not in humans will not be considered.